| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/15/2012 | CN102351631A Alpha-pinene extracted from pine needle, its extraction method and application for resisting tumor |
| 02/15/2012 | CN102350001A Preparation method of heterologous bluetongue virus double-strand RNA (ribonucleic acid) endogenous interferon inducer |
| 02/15/2012 | CN102350000A Application of heterogeneous bluetongue virus dsRNA (double-strand ribonucleic acid) in preparation of endogenic interferon inducer |
| 02/15/2012 | CN102349999A Multifunctional adriamycin precursor medicament as well as preparation method and application thereof |
| 02/15/2012 | CN102349998A Hydrophobic anticancer medicinal preparation on basis of exosome |
| 02/15/2012 | CN102349997A Diagnosis and prevention of cancer cell invasion |
| 02/15/2012 | CN102349982A Traditional Chinese medicine composition for cancer rehabilitation |
| 02/15/2012 | CN102349978A Application of hematogenesis pills in preparation of drug for preventing cell trauma caused by low-dose ionizing radiation |
| 02/15/2012 | CN102349954A Method for auxiliarily extracting Zanthoxylum nitidum alkaloid through steam explosion |
| 02/15/2012 | CN102349943A Juglans mandshurica husk extractive and preparation method thereof |
| 02/15/2012 | CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances |
| 02/15/2012 | CN102349937A Preparation method of ixeris sonchifolia hance extractive |
| 02/15/2012 | CN102349934A Extraction process of effective ingredients from cordyceps mycelia |
| 02/15/2012 | CN102349927A Combination methods of treating cancer |
| 02/15/2012 | CN102349924A Centella asiatica triterpenic acid single-glucopyranoside composition, its preparation method, its quantitative analysis method and its application |
| 02/15/2012 | CN102349917A Application and preparation method of tripterine |
| 02/15/2012 | CN102349890A Application of thaspine derivative HMQ1611 in inhibition of mammary cancer |
| 02/15/2012 | CN102349875A Preparation method of methylsulfonic acid imatinib tablet |
| 02/15/2012 | CN102349874A Imatinib mesylate composition and preparation method thereof |
| 02/15/2012 | CN102349871A Nano-micro drug delivery system and preparation method of 10-hydroxyl camptothecin |
| 02/15/2012 | CN102349868A Preparation method of targeting folic acid-hydrophobic anticancer drug hydrogel |
| 02/15/2012 | CN102349701A Chinese herbal medicine cigarette and manufacturing method thereof |
| 02/15/2012 | CN102114152B 一种治疗中晚期食道癌的药物及其制备方法 An advanced esophageal cancer treatment drug and its preparation method |
| 02/15/2012 | CN102085217B 含有药用钙盐的早期预防大肠腺瘤或者大肠癌的药物组合物 Early pharmaceutical compositions comprising a pharmaceutically acceptable calcium salt of prevention of colorectal adenomas or colorectal cancer |
| 02/15/2012 | CN102068431B 一种咔唑磺酰胺类抗肿瘤药物片剂及其制备方法 One kind of carbazole sulfonamide anticancer drugs tablets and its preparation method |
| 02/15/2012 | CN101948464B 3,4,6-三芳基-[1,3]-噁嗪-2-酮类化合物、其制备方法和用途 3,4,6-triaryl - [1,3] - oxazin-2-ones compounds, their preparation and use |
| 02/15/2012 | CN101854919B 用于治疗肿瘤疾病的组合物 For the treatment of neoplastic diseases compositions |
| 02/15/2012 | CN101843894B 南瓜蛋白在制备治疗肺癌药物中的应用 Pumpkin protein in the manufacture of a medicament for the treatment of lung cancer |
| 02/15/2012 | CN101822841B 有机胺衍生物作为小分子药物脑靶向修饰基团的用途 Organic amine derivatives as small molecule drugs targeting the brain uses a modified group |
| 02/15/2012 | CN101822642B 一种载有抗肿瘤血管生成药物的多肽修饰的隐形纳米粒及其应用 A carrier with anti-angiogenesis drugs stealth nanoparticles modified polypeptide and its application |
| 02/15/2012 | CN101785865B pH响应型两亲接枝聚膦腈给药胶束及其制备方法 pH-responsive amphiphilic graft polyphosphazene micelles and preparation method of administration |
| 02/15/2012 | CN101773625B 一种抗癌药及其制备方法和应用 An anti-cancer drug and its preparation method and application |
| 02/15/2012 | CN101732715B LSECtin及其融合蛋白在制备抑制癌细胞向肝转移药物中的应用 LSECtin and fusion proteins to inhibit cancer metastases in the manufacture of medicaments |
| 02/15/2012 | CN101724091B 活性羧甲基茯苓多糖及其生产工艺和应用 Activity carboxymethyl Pachymaran its production processes and applications |
| 02/15/2012 | CN101716348B 一种基于金磁纳米粒子的载药平台的构建与应用 Construction and Application of gold based on magnetic nanoparticles drug loading platform |
| 02/15/2012 | CN101678121B 对肿瘤细胞具有杀伤作用的改性羟基聚合物共轭物 Hydroxyl polymer-modified tumor cell killing effect of having a conjugate |
| 02/15/2012 | CN101636414B 聚乙二醇修饰的干扰素α2b及其制备方法和应用 Pegylated interferon α2b and its preparation method and application |
| 02/15/2012 | CN101530389B 人参皂苷Rg3磷脂复合物及其制备方法 Ginsenoside Rg3 phospholipid complex and its preparation method |
| 02/15/2012 | CN101475503B 一种新型阳离子类脂及其制备方法和应用 A novel cationic lipid and its preparation method and application |
| 02/15/2012 | CN101433557B 一种五倍子的有效组分及其制备方法与用途 Effective ingredients and preparation method and uses gall |
| 02/15/2012 | CN101396367B 通关藤新甙b在制备治疗肿瘤疾病的药物中的应用及制备 Marsdenia new glycosides b Application in Preparation and treatment of neoplastic diseases in |
| 02/15/2012 | CN101347508B 防己有效组分及其制备方法 Tetrandra effective ingredients and preparation methods |
| 02/15/2012 | CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic |
| 02/15/2012 | CN101085743B 含氟烷氧基康普立停衍生物及制法和用途 Fluoroalkyloxy Kang Puli parked containing derivatives and preparation method and uses |
| 02/15/2012 | CN101044114B 硝基苯并吲哚和它们在癌症疗法中的用途 Nitrobenzene and indole and their use in cancer therapy in the |
| 02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114901 Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride |
| 02/14/2012 | US8114885 Chemical compounds |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114840 Medicament containing activated antithrombin III |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 02/14/2012 | US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 02/14/2012 | US8114405 Cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS) |
| 02/14/2012 | US8114395 Treatment of viral diseases with recombinant interferon α |
| 02/14/2012 | CA2651653C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/14/2012 | CA2343135C Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 02/11/2012 | CA2712747A1 Combinatory cancer treatment |
| 02/09/2012 | WO2012019184A2 Compositions and methods for detecting, diagnosing, and treating cancer |
| 02/09/2012 | WO2012019024A2 Her3-binding molecules and immunoconjugates thereof |
| 02/09/2012 | WO2012019015A2 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases |
| 02/09/2012 | WO2012018949A2 Compositions and methods for the treatment of cancer |
| 02/09/2012 | WO2012018932A2 Compounds and compositions for mitigating tissue damage and lethality |
| 02/09/2012 | WO2012018877A2 Treating breast cancer with anti-il-19 antibody |
| 02/09/2012 | WO2012018866A2 Methods and compositions for the diagnosis and treatment of breast cancer |
| 02/09/2012 | WO2012018854A2 Pactamycin analogs and methods of use |
| 02/09/2012 | WO2012018801A2 Suppressing bone loss with anti-il-19 antibody |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018761A2 Method of treatment of androgen-mediated cancers |
| 02/09/2012 | WO2012018759A2 Method of treatment of androgen-mediated cancers |
| 02/09/2012 | WO2012018597A2 Compositions and methods for enhancing the effectiveness of systemic, hipec, ip, and related cancer treatments |
| 02/09/2012 | WO2012018383A2 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 02/09/2012 | WO2012018380A2 Compositions and methods for inducing immune tolerance |
| 02/09/2012 | WO2012018260A1 Epidermal growth factor receptor targeted immune therapy |
| 02/09/2012 | WO2012018235A2 Method for preparing decitabine with improved yield and purity |
| 02/09/2012 | WO2012018145A2 Agent for improving quality of life |
| 02/09/2012 | WO2012017700A1 Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 02/09/2012 | WO2012017551A1 Therapeutic agent for disease |
| 02/09/2012 | WO2012017454A1 Coumarin-chalcones as anticancer agents |
| 02/09/2012 | WO2012017451A1 A bio-stabilized resveratrol formulation |
| 02/09/2012 | WO2012017251A1 N-acylsulfonamide apoptosis promoters |
| 02/09/2012 | WO2012017239A2 Chemical compounds |
| 02/09/2012 | WO2012017004A1 Novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties |
| 02/09/2012 | WO2012016994A1 Bone-targeting bisphosphonate duplex drugs |
| 02/09/2012 | WO2012016993A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 02/09/2012 | WO2012016970A1 A crystalline form of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4 -methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl)-amide and its use as pi3k inhibitor |
| 02/09/2012 | WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 02/09/2012 | WO2012016918A1 Use of a peptide enhancing the ability of radiation therapy to kill cancer cells |
| 02/09/2012 | WO2012016706A1 Composition comprising retinol, a precursor or a reaction product of it and a plant extract from at least one chamomilla plant for the treatment of cancer |
| 02/09/2012 | WO2012016367A1 Trehalose derivatives, preparation methods and uses thereof |
| 02/09/2012 | WO2011133637A3 Compounds and methods for kinase modulation, and indications therefor |
| 02/09/2012 | WO2011127232A3 Substituted androst-4-ene diones |
| 02/09/2012 | US20120035529 Tumor vascular marker-targeted vaccines |
| 02/09/2012 | US20120035409 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 02/09/2012 | US20120035408 Compounds useful as inhibitors of atr kinase |
| 02/09/2012 | US20120035407 Compounds useful as inhibitors of atr kinase |